Tag: NIH

  • Artificial Kidney Project Lands New $750,000 Funding

    The Kidney Project, an academic-corporate initiative led by University of California in San Francisco to develop an implantable device to replace failed kidneys, secured a new $750,000 grant from the John and Marcia Goldman Foundation. The funding supplements a $2.25 million grant received this summer from National Institutes of Health (NIH). The artificial kidney aims…

  • Clinical Trial to Evaluate Type 2 Diabetes Treatments

    A clinical trial coordinated by George Washington University in Washington, D.C. will test the effectiveness of glucose-lowering drugs in treating type 2 diabetes. The five year, $134 million study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at National Institute of Health. John Lachin, professor of biostatistics, epidemiology and…

  • SBIR Grant to Support Glucagon Made for Artificial Pancreas

    National Institutes of Health (NIH) awarded Biodel Inc.,  a biopharmaceutical company in Danbury, Connecticut, a Small Business Innovation Research grant to develop a special form of glucagon used in artificial pancreas systems for diabetes patients. Small Business Innovation Research (SBIR) grants are awarded by U.S. federal science agencies to encourage smaller enterprises to explore research…

  • NIH Grant to Fund Translational Research on Blood Clotting

    National Institutes of Health will fund a translational research center at University of Utah in Salt Lake City to study the cellular and molecular causes of blood clots. Andew Weyrich, a professor medicine at Utah, will lead the five-year, $16 million effort. The new Translational Research Center in Thrombosis aims to find new diagnostic, preventative,…

  • Biopharm Gains SBIR Grant for Cystic Fibrosis Treatment

    OrPro Therapeutics Inc., a biopharmaceutical company in San Diego, received a Small Business Innovation Research (SBIR) grant from National Institutes of Health, to advance development of its lead product, ORP-100, for the treatment of cystic fibrosis. The company did not disclose the amount of the award from the National Heart, Lung and Blood Institute of…

  • Award Funds Malaria Drug Anti-Counterfeiting Technology

    The organization Saving Lives at Birth has awarded a Boston University engineering professor a grant to complete development of technology that can determine the potency of drugs like those to treat malaria. The two-year $250,000 grant will fund Muhammad Zaman’s (pictured left) work on PharmaCheck, a handheld microfluidic — lab-on-a-chip — device. PharmaCheck scans pills…

  • Small Business Grant Awarded for Artificial Pancreas Insulin

    Biodel Inc., a biopharmaceutical company in Danbury, Connecticut, has received a Small Business Innovation Research (SBIR) grant to develop concentrated faster-acting insulin formulations for use in an artificial pancreas. The two-year grant totaling $582,473 was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases of National Institutes of Health (NIH). Biodel notes…

  • Lymphoma Drug Found to Uncover Dormant HIV

    A team led by researchers at University of North Carolina in Chapel Hill have found a drug given to fight lymphoma was able to dislodge heretofore hidden virus in patients with HIV. The findings appear online in this week’s issue of the journal Nature (paid subscription required). The researchers, led by UNC medical professor David…

  • NIH to Fund Development of Organ-On-Chip Devices

    National Institutes of Health will support 17 research initiatives leading to development of microfluidic chips that simulate the structure and function of human organs. NIH’s National Center for Advancing Translational Sciences is funding the projects for five years at a total cost of $70 million. The project involves collaboration with the Defense Advanced Research Projects…

  • Agilent, University, Agencies to Partner on Pathogen Genomes

    Agilent Technologies Inc. in Santa Clara, California is collaborating with University of California in Davis, Food and Drug Administration, and Centers for Disease Control and Prevention on collecting a database of 100,000 foodborne pathogen genomes. The 100K Genome Project aims to sequence the genetic code of some 100,000 foodborne pathogens over five years, and make…